Rapid itch relief with the biologic agent nemolizumab in Atopic dermatitis and Prurigo nodularis: Promise, complexity and clinical implications. [PDF]
Lukaschek K, Weisshaar E.
europepmc +1 more source
Prurigo nodularis enters the biologic era: what has changed and what vixarelimab still must prove
Mohammed Shanshal
doaj +1 more source
A Conceptual Disease Model of Symptoms and Impacts in Adults with Prurigo Nodularis: A Qualitative and Literature-Informed Study. [PDF]
Kwatra SG +6 more
europepmc +1 more source
Dupilumab in moderate-to-severe prurigo nodularis: Real-world data from early access program. [PDF]
Jachiet M +14 more
europepmc +1 more source
Comprehensive Transcriptomic Profiling of Nonatopic Prurigo Nodularis in Korean Patients Reveals Il-22-driven Epidermal Stress and Neuro-immuno-fibrotic Remodelling. [PDF]
Kim HS, Kim YS, Yosipovitch G.
europepmc +1 more source
Trastuzumab-associated prurigo nodularis successfully treated with nemolizumab: A case report. [PDF]
Chen R +5 more
europepmc +1 more source
Recalcitrant Prurigo Nodularis Successfully Treated with Dupilumab
Gopikrishnan Anjaneyan +3 more
doaj +1 more source
Dermoscopy of Prurigo Nodularis/Lichen Simplex Chronicus of the Scalp: A Comparative Observational Study in Fair and Dark Skin. [PDF]
Plozner N +7 more
europepmc +1 more source
Immunometabolic reprogramming in the management of prurigo nodularis with methotrexate. [PDF]
Liao V +7 more
europepmc +1 more source
Transcriptomic analysis of skin biopsies in Prurigo nodularis patients: with and without atopic dermatitis. [PDF]
Lee SY +7 more
europepmc +1 more source

